[1]
D. Recart, “Hypomagnesemia in proton pump inhibitors use: prevalence and risk factors”, Rev Hosp Ital B.Aires, vol. 40, no. 4, pp. 225–226, Dec. 2020, doi: 10.51987/revhospitalbaires.v40i4.40.